Swisstek (Ceylon) Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Swisstek (Ceylon) heeft een totaal eigen vermogen van LKR2.7B en een totale schuld van LKR6.4B, wat de schuld-eigenvermogensverhouding op 236.9% brengt. De totale activa en totale passiva bedragen respectievelijk LKR12.0B en LKR9.3B. De EBIT Swisstek (Ceylon) is LKR1.2B waardoor de rentedekking 3.4 is. Het heeft contanten en kortetermijnbeleggingen van LKR419.1M.

Belangrijke informatie

236.9%

Verhouding schuld/eigen vermogen

LK₨6.35b

Schuld

Rente dekkingsratio	3.4x
Contant	LK₨419.13m
Aandelen	LK₨2.68b
Totaal verplichtingen	LK₨9.34b
Totaal activa	LK₨12.03b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( LKR7.6B ) PARQ.N0000 } overtreffen de korte termijn passiva ( LKR6.7B ).

Langlopende schulden: De kortetermijnactiva PARQ.N0000 ( LKR7.6B ) overtreffen de langetermijnschulden ( LKR2.6B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 221.3% ) PARQ.N0000 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van PARQ.N0000 is de afgelopen 5 jaar gestegen van 150.1% naar 236.9%.

Schuldendekking: De schuld van PARQ.N0000 wordt niet goed gedekt door de operationele kasstroom ( 3.4% ).

Rentedekking: De rentebetalingen op de schuld van PARQ.N0000 worden goed gedekt door EBIT ( 3.4 x dekking).

Swisstek (Ceylon) Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Second quarter 2025 earnings released: EPS: LK₨1.63 (vs LK₨0.055 in 2Q 2024)

Investor sentiment improves as stock rises 18%

MD & Executive Director recently bought LK₨2.0m worth of stock

Investor sentiment improves as stock rises 18%

First quarter 2025 earnings released: EPS: LK₨0.58 (vs LK₨1.16 loss in 1Q 2024)

Upcoming dividend of LK₨0.30 per share

Full year 2024 earnings released: LK₨0.51 loss per share (vs LK₨4.15 loss in FY 2023)

Dividend of LK₨0.30 announced

New minor risk - Share price stability

Upcoming dividend of LK₨0.50 per share

Dividend reduced to LK₨0.50

Third quarter 2024 earnings released: LK₨0.43 loss per share (vs LK₨1.99 loss in 3Q 2023)

Second quarter 2024 earnings released: LK₨0.16 loss per share (vs LK₨0.12 profit in 2Q 2023)

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: LK₨1.16 loss per share (vs LK₨0.28 loss in 1Q 2023)

Upcoming dividend of LK₨0.20 per share at 7.7% yield

Swisstek (Ceylon) PLC, Annual General Meeting, Jun 30, 2023

Swisstek (Ceylon) plc Proposes Final Dividend

Full year 2023 earnings released: LK₨4.15 loss per share (vs LK₨6.16 profit in FY 2022)

MD & Executive Director recently bought LK₨463k worth of stock

Third quarter 2023 earnings released: LK₨1.99 loss per share (vs LK₨2.41 profit in 3Q 2022)

Insufficient new directors

Second quarter 2023 earnings released: EPS: LK₨0.12 (vs LK₨1.40 in 2Q 2022)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Director recently bought LK₨4.3m worth of stock

First quarter 2023 earnings released: LK₨0.28 loss per share (vs LK₨0.49 profit in 1Q 2022)

Investor sentiment improved over the past week

MD & Executive Director recently bought LK₨274k worth of stock

Investor sentiment improved over the past week

Swisstek (Ceylon) PLC, Annual General Meeting, Jun 29, 2022

Upcoming dividend of LK₨0.90 per share

Full year 2022 earnings released: EPS: LK₨6.16 (vs LK₨4.37 in FY 2021)

Investor sentiment improved over the past week

MD & Executive Director recently bought LK₨150k worth of stock

Investor sentiment deteriorated over the past week

Insufficient new directors

Insufficient new directors

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of LK₨1.00 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

MD & Executive Director recently bought LK₨232k worth of stock

Director recently sold LK₨16m worth of stock

Director recently sold LK₨16m worth of stock

Investor sentiment improved over the past week

Second quarter 2022 earnings released

Upcoming dividend of LK₨0.80 per share

Director recently bought LK₨7.0m worth of stock

First quarter 2022 earnings released: EPS LK₨0.49 (vs LK₨0.21 loss in 1Q 2021)

Full year 2021 earnings released: EPS LK₨4.37 (vs LK₨1.26 in FY 2020)

Investor sentiment deteriorated over the past week

Director recently sold LK₨12m worth of stock

Upcoming Dividend of LK₨4.10 Per Share

Third quarter 2021 earnings released: EPS LK₨6.04 (vs LK₨2.28 in 3Q 2020)

Investor sentiment improved over the past week

New 90-day high: LK₨141

New 90-day high: LK₨101

New 90-day high: LK₨85.20

Director recently sold LK₨8.0m worth of stock

Market bids up stock over the past week

Second quarter 2021 earnings released: EPS LK₨5.51

New 90-day high: LK₨68.20

Market bids up stock over the past week

MD & Executive Director recently bought LK₨817k worth of stock

Market bids up stock over the past week

New 90-day high: LK₨51.10

New 90-day high: LK₨46.50

New 90-day high - LK₨43.50

First quarter earnings released

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven